Advertisement

Index by author

May 01, 1995; Volume 47,Issue 5

  1. Kankaanranta, H

    1. Flufenamic and tolfenamic acids inhibit calcium influx in human polymorphonuclear leukocytes.
      H Kankaanranta and E Moilanen
      Molecular Pharmacology May 1995, 47 (5) 1006-1013;

  2. Keating, M J

    1. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
      L Y Yang, L Li, M J Keating and W Plunkett
      Molecular Pharmacology May 1995, 47 (5) 1072-1079;

  3. Kepler, J A

    1. Interaction of dolastatin 10 with tubulin: induction of aggregation and binding and dissociation reactions.
      R Bai, G F Taylor, J M Schmidt, M D Williams, J A Kepler, G R Pettit and E Hamel
      Molecular Pharmacology May 1995, 47 (5) 965-976;

  4. Kitabgi, P

    1. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
      C Labbé-Jullié, J M Botto, M V Mas, J Chabry, J Mazella, J P Vincent, D Gully, J P Maffrand and P Kitabgi
      Molecular Pharmacology May 1995, 47 (5) 1050-1056;

  5. Klein, D C

    1. Vasoactive intestinal peptide elevates pinealocyte intracellular calcium concentrations by enhancing influx: evidence for involvement of a cyclic GMP-dependent mechanism.
      N C Schaad, J Vanecek, I R Rodriguez, D C Klein, L Holtzclaw and J T Russell
      Molecular Pharmacology May 1995, 47 (5) 923-933;

  6. Knecht, K T

    1. Free radical adducts in the bile of rats treated chronically with intragastric alcohol: inhibition by destruction of Kupffer cells.
      K T Knecht, Y Adachi, B U Bradford, Y Iimuro, M Kadiiska, Q H Xuang and R G Thurman
      Molecular Pharmacology May 1995, 47 (5) 1028-1034;

  7. Knox, R

    1. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
      S Chen, R Knox, A D Lewis, F Friedlos, P Workman, P S Deng, M Fung, D Ebenstein, K Wu and T M Tsai
      Molecular Pharmacology May 1995, 47 (5) 934-939;

  8. Krause, J E

    1. Residue 78 in the second transmembrane domain of the neurokinin-1 receptor is important in coupling high affinity agonist binding to multiple second messenger responses.
      R M Brodbeck, B S Sachais and J E Krause
      Molecular Pharmacology May 1995, 47 (5) 1065-1071;

  9. Kuznetsov, A

    1. kappa-Opioid receptor activates an inwardly rectifying K+ channel by a G protein-linked mechanism: coexpression in Xenopus oocytes.
      G H Ma, R J Miller, A Kuznetsov and L H Philipson
      Molecular Pharmacology May 1995, 47 (5) 1035-1040;

  10. Labbe-jullie, C

    1. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
      C Labbé-Jullié, J M Botto, M V Mas, J Chabry, J Mazella, J P Vincent, D Gully, J P Maffrand and P Kitabgi
      Molecular Pharmacology May 1995, 47 (5) 1050-1056;
« Previous (Pages : 2 3 4 5 6 7 8 9 10 11 ... 13) Next »
Back to top

In this issue

Advertisement